These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2889964)

  • 1. Oesophageal varices associated with busulphan-thioguanine combination therapy for chronic myeloid leukaemia.
    Key NS; Kelly PM; Emerson PM; Chapman RW; Allan NC; McGee JO
    Lancet; 1987 Nov; 2(8567):1050-2. PubMed ID: 2889964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioguanine used in maintenance therapy of chronic myeloid leukaemia causes non-cirrhotic portal hypertension. Results from MRC CML. II. Trial comparing busulphan with busulphan and thioguanine.
    Shepherd PC; Fooks J; Gray R; Allan NC
    Br J Haematol; 1991 Oct; 79(2):185-92. PubMed ID: 1958475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal hypertension in a patient with chronic myeloid leukaemia.
    Foadi MD; Shaw S; Paradinas FJ
    Postgrad Med J; 1977 May; 53(619):267-9. PubMed ID: 267281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-Thioguanine-related chronic hepatotoxicity and variceal haemorrhage in children treated for acute lymphoblastic leukaemia--a dual-centre experience.
    Ravikumara M; Hill FG; Wilson DC; Gillett PM; Thomas A; Brown R; Darbyshire PJ; McKiernan PJ
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):535-8. PubMed ID: 16707977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variceal hemorrhage in a patient with ulcerative colitis treated with 6-Thioguanine.
    Fritz E; Wrba F; Knoflach P
    Inflamm Bowel Dis; 2008 Apr; 14(4):582-3. PubMed ID: 18183610
    [No Abstract]   [Full Text] [Related]  

  • 6. The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease.
    van Asseldonk DP; Jharap B; Verheij J; den Hartog G; Westerveld DB; Becx MC; Russel MG; Engels LG; de Jong DJ; Witte BI; Mulder CJ; van Nieuwkerk CM; Bloemena E; de Boer NK; van Bodegraven AA
    Inflamm Bowel Dis; 2016 Sep; 22(9):2112-20. PubMed ID: 27482972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thioguanine as primary treatment for chronic granulocytic leukaemia.
    Spiers AS; Galton DA; Kaur J; Goldman JM
    Lancet; 1975 Apr; 1(7911):829-32. PubMed ID: 48057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension.
    Ferlitsch A; Teml A; Reinisch W; Ulbrich G; Wrba F; Homoncik M; Gangl A; Peck-Radosavljevic M; Vogelsang H
    Am J Gastroenterol; 2007 Nov; 102(11):2495-503. PubMed ID: 17894846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic problems in nodular regenerative hyperplasia (nodular transformation) of the liver. Review of the literature and report of two cases.
    Trauner M; Stepan KM; Resch M; Ebner F; Pristautz H; Klimpfinger M
    Z Gastroenterol; 1992 Mar; 30(3):187-94. PubMed ID: 1590015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding oesophageal varices associated with anabolic steroid use in an athlete.
    Winwood PJ; Robertson DA; Wright R
    Postgrad Med J; 1990 Oct; 66(780):864-5. PubMed ID: 2099434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited relevance and progression of histological alterations in the liver during thioguanine therapy in inflammatory bowel disease patients.
    van Asseldonk DP; Simsek M; de Boer NKH; Jharap B; Bloemena E; den Hartog G; Westerveld DB; Becx MC; Russel MG; Lissenberg-Witte BI; van Nieuwkerk CM; Mulder CJJ; Verheij J; van Bodegraven AA
    Scand J Gastroenterol; 2019 Jun; 54(6):753-760. PubMed ID: 31203688
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of chronic granulocytic leukaemia with repeated single doses of busulphan.
    Vicariot M; Goldman JM; Catovsky D; Galton DA
    Eur J Cancer (1965); 1979 Apr; 15(4):559-63. PubMed ID: 285861
    [No Abstract]   [Full Text] [Related]  

  • 13. [Nodular regenerative hyperplasia associated with common variable immunodeficiency and other comorbidities].
    León R; Sánchez-Martínez R; Palazón JM; Payá A; Ramos JM; Pinargote H
    Med Clin (Barc); 2016 Mar; 146(6):263-6. PubMed ID: 26723943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oesophageal variceal bleeding in Felty's syndrome associated with nodular regenerative hyperplasia.
    Blendis LM; Lovell D; Barnes CG; Ritland S; Cattan D; Vesin P
    Ann Rheum Dis; 1978 Apr; 37(2):183-6. PubMed ID: 306226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients.
    de Boer NK; Zondervan PE; Gilissen LP; den Hartog G; Westerveld BD; Derijks LJ; Bloemena E; Engels LG; van Bodegraven AA; Mulder CJ
    Dig Liver Dis; 2008 Feb; 40(2):108-13. PubMed ID: 18083079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular regenerative hyperplasia with portal hypertension in a patient with myasthenia gravis.
    Eliakim R; Ligumsky M; Jurim O; Shouval D
    Am J Gastroenterol; 1987 Jul; 82(7):674-6. PubMed ID: 3496785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of the myeloid leukaemias.
    Stuart J
    J R Coll Physicians Lond; 1980 Jan; 14(1):36-41. PubMed ID: 7003128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nodular regenerative hyperplasia as a complication of thiopurine treatment in a patient with inflammatory bowel disease].
    Cohen-Ezra O; Avni Y; Morgenstern S; Ben-Ari Z
    Harefuah; 2012 Dec; 151(12):675-8, 721. PubMed ID: 23330258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodular regenerative hyperplasia of the liver: survival and associated features in a UK case series.
    Morris JM; Oien KA; McMahon M; Forrest EH; Morris J; Stanley AJ; Campbell S
    Eur J Gastroenterol Hepatol; 2010 Aug; 22(8):1001-5. PubMed ID: 20075739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jaundice after treatment of leukemia with busulphan.
    Underwood JC; Shahani RT; Blackburn EK
    Br Med J; 1971 Mar; 1(5748):556-7. PubMed ID: 5280623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.